Evidence map›Paper›PMID 31736862›Full record

ArticleFrontiers in neurology2019

Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype.

Laura Navarro Cantó, Sara Carratalá Boscá, Carmen Alcalá Vicente, Sara Gil-Perontín, Francisco Pérez-Miralles, Jessica Castillo Villalba, Laura Cubas Nuñez, Bonaventura Casanova Estruch

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Laura Navarro CantóDepartament of Neurology, Hospital General Universitario de Elche, Alicante, Spain.
Sara Carratalá BoscáNeuroimunology and Multiple Sclerosis Research Group, Hospital Universitari i Politècnic La Fe de València, Valencia, Spain.
Carmen Alcalá VicenteNeuroimmmunology Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Sara Gil-PerontínNeuroimunology and Multiple Sclerosis Research Group, Hospital Universitari i Politècnic La Fe de València, Valencia, Spain.
Francisco Pérez-MirallesNeuroimmmunology Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Jessica Castillo VillalbaNeuroimunology and Multiple Sclerosis Research Group, Hospital Universitari i Politècnic La Fe de València, Valencia, Spain.
Laura Cubas NuñezNeuroimunology and Multiple Sclerosis Research Group, Hospital Universitari i Politècnic La Fe de València, Valencia, Spain.
Bonaventura Casanova EstruchNeuroimmmunology Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Hospital Universitari i Politècnic La Fe · ESHospital General Universitario de Elche · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-MOG antibodiesbiomarkerbrain atrophyCRIONoptic neuritis

Identifiers

PMID31736862
PMCPMC6838209
OpenAlexW2989232288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.